The MedicX Fund Limited
08 March 2007
For immediate release 8th March 2007
MedicX Fund Limited
('MedicX Fund', 'the Fund' or 'the Company')
Board Change
The Board of MedicX Fund announces with regret that Jorge Tavares will be
standing down from the Board, with immediate effect, following an injury, which
prevents him from fulfilling his duties as Chairman of the Company. It is hoped
that he will be able to be reappointed to the Board once he has recovered. If
Jorge has not made a recovery by 1 July 2007, a replacement Chairman will be
sought.
John Hearle, speaking on behalf of the Board, said: 'The Directors are sorry
that Jorge is unable to act in his capacity as Chairman. However, we look
forward to him making a speedy recovery and returning shortly.'
For further information please contact:
MedicX Group +44(0) 1483 869500
Keith Maddin, Chairman
Mike Adams, Managing Director
Buchanan Communications +44 (0) 20 7466 5000
Charles Ryland / Lisa Baderoon / Mary-Jane Johnson
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.